Cite
HARVARD Citation
Dejust, S. et al. (2016). 18F-FDG PET/CT Evaluation of Ceritinib Therapy in Metastatic ALK-Positive Non–small Cell Lung Cancer. Clinical nuclear medicine. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dejust, S. et al. (2016). 18F-FDG PET/CT Evaluation of Ceritinib Therapy in Metastatic ALK-Positive Non–small Cell Lung Cancer. Clinical nuclear medicine. p. . [Online].